Assay and Drug Development Technologies

Papers
(The H4-Index of Assay and Drug Development Technologies is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
On the Recent Changes to Animal Protection Measures in United States Food and Drug Administration Policy43
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line27
A Perspective on Various Facets of Nanoemulsions and its Commercial Utilities23
Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective18
Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems15
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes14
Investigating the Role of Buzhong Yiqi Decoction on Neurogenic Bladder with Network Pharmacology, Molecular Docking, and In Vitro Assays14
Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument13
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells13
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability Modifier12
Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen12
Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes12
Spatiotemporal Nanocarriers for Circadian-Aligned Drug Delivery: Advances, Challenges, and Future Directions12
Targeted Drug Delivery with Nanosponges and Nanocrystals: Innovations, Formulation Strategies, and Applications12
0.054480075836182